No image

ARK™ HS Benzodiazepine II Assay

The ARK™ HS Benzodiazepine II Assay is intended for the qualitative and/or semiquantitative determination of benzodiazepines in human urine at cutoff concentrations of 100 ng/mL and 200 ng/mL. The assay provides a simple and rapid analytical screening procedure for detecting benzodiazepines in urine and is designated for professional use on automated clinical chemistry analyzers.

Details

Device typeBenzodiazepine group IVD, kit, enzyme immunoassay (EIA): A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of one or multiple benzodiazepines in a clinical specimen, using an enzyme immunoassay (EIA) method.

FDA categoryEnzyme Immunoassay, Benzodiazepine

Device ID00812101030493

Catalog number5073-0001-02

AvailabilityPrescription

Single useYes

MRI safetyLabeling does not contain MRI Safety Information

Contact

Phone5102706270

Emailcustomersupport@ark-tdm.com

Related products

Product	Model	Company	Device type
Pointe Barbiturate Reagent SetHoriba Instruments IncorporatedBarbiturate IVD, kit, enzyme immunoassay (EIA)	60-BA0280-1L	Horiba Instruments Incorporated	Barbiturate IVD, kit, enzyme immunoassay (EIA)
Syva® Emit® II Plus Barbiturate AssaySiemens Healthcare Diagnostics Inc.Barbiturate IVD, kit, enzyme immunoassay (EIA)	10445423	Siemens Healthcare Diagnostics Inc.	Barbiturate IVD, kit, enzyme immunoassay (EIA)
ARK™ Methotrexate II AssayArk Diagnostics IncMethotrexate therapeutic drug monitoring IVD, kit, enzyme immunoassay (EIA)	5071-0001-00	Ark Diagnostics Inc	Methotrexate therapeutic drug monitoring IVD, kit, enzyme immunoassay (EIA)
ARK™ Pregabalin II AssayArk Diagnostics IncMultiple anticonvulsant therapeutic drug monitoring IVD, reagent	5059-0001-01	Ark Diagnostics Inc	Multiple anticonvulsant therapeutic drug monitoring IVD, reagent